Autopsy report · NCT03436732

Mesothelin-Targeted Immunotoxin LMB-100 in Combination With SEL-110 in Subjects With Malignant Pleural or Peritoneal Mesothelioma

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Due to fatal occurrence (pneumonitis) attributed to one of the study drugs.”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 1 year 2 months before it stopped.
5 participants enrolled.
Results were posted on the registry 7 months after it ended.

Vital statistics

Status: Terminated
Phase: Phase 1
Sponsor: National Cancer Institute (NCI)
Sponsor type: US National Institutes of Health
Conditions: Mesothelioma
Interventions: LMB-100; SEL-110
Participants: 5
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.